✦ LIBER ✦

Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy

✍ Scribed by Niederle, N. ;Schütte, J. ;Schmidt, C. G.

Publisher: Springer-Verlag
Year: 1986
Tongue: English
Weight: 434 KB
Volume: 64
Category: Article
ISSN: 1432-1440
DOI: 10.1007/bf01728184

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind comparison of

A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin

✍ Suzanne H. Stephens; V. Lee Silvey; Richard H. Wheeler 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views

Thirty-seven patients with advanced incurable malignancies who were receiving their first course of cisplatin (2 90 mg/mz bolus), alone or in combination with other antineoplastic agents, were entered in this randomized, double-blind study to determine the antiemetic efficacy of the addition of high

Open-label comparison of the antiemetic

Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy

✍ Coppes, Max J.; Lau, Robert; Ingram, Lewis C.; Wiernikowski, John T.; Grant, Ron 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Background. Nausea and vomiting are among the most unpleasant adverse side effects of cancer therapy. Procedure. An open-label dose-escalation study was conducted to assess the appropriate intravenous dose of dolasetron for pediatric patients undergoing chemotherapy. Patients received dolasetron in